Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Head and Neck Neoplasms × Erythropoietin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Anemia 4 Uterine Cervical Neoplasms 2 Myelodysplastic Syndromes 2 Leukemia 2 Rectal Neoplasms 1 Radiation Injuries 1 Prostatic Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Neoplasms 1 Lymphoma 1 Lichen Planus, Oral 1 Leukemia, Myelomonocytic, Chronic 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Erectile Dysfunction 1 Drug-Related Side Effects and Adverse Reactions 1

Interventions

Cisplatin 227 Radiotherapy 174 Cetuximab 129 pembrolizumab 106 Fluorouracil 84 Docetaxel 82 Paclitaxel 73 Carboplatin 69 Radiotherapy, Intensity-Modulated 65 Surveys and Questionnaires 40 Nivolumab 39 Radiation 31 Drug Therapy 28 Blood Specimen Collection 24 Gemcitabine 23 Immunohistochemistry 22 Gefitinib 20 Erlotinib Hydrochloride 20 Surgical Procedures, Operative 19 Magnetic Resonance Spectroscopy 19 durvalumab 18 Standard of Care 18 Pemetrexed 17 Cyclophosphamide 17 atezolizumab 15 Gene Expression Profiling 15 Capecitabine 15 Biopsy 15 Radiosurgery 14 Low-Level Light Therapy 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01467115 2017-05-09

DREXNECK

Drexel University

Phase 2 Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡